Protective efficacy of recombinant canine adenovirus type-2 expressing TgROP18 (CAV-2-ROP18) against acute and chronic Toxoplasma gondii infection in mice

Overview of attention for article published in BMC Infectious Diseases, March 2015

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,277 followers.

Adap: Protective efficacy of recombinant canine adenovirus type-2 expressing TgROP18 (CAV-2-ROP18) against acute… https://t.co/fvH6OscnmP

Protective efficacy of recombinant canine adenovirus type-2 expressing TgROP18 (CAV-2-ROP18… http://t.co/Bif4H0xN8x